Physician profile
Susan D Earls
NPI 1477613891
$4,904.91
in general payments reported to CMS, 2019-2025
16 companies · $721 in 2025
The $721 reported for 2025 was more than what 86% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $422 · 2022: $849 · 2023: $942 · 2024: $1,971 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,633.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,458.21 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $1,092.14 | 2022-2025 | Proclaim, Eterna |
| Nevro Corp. | $572.05 | 2022-2023 | Senza |
| Orthofix Medical, INC. | $364.43 | 2021-2022 | |
| Abbvie INC. | $301.76 | 2021-2025 | |
| Medacta USA, INC. | $273.06 | 2023-2024 | Mectalif |
| Biotronik Nro, INC. | $223.37 | 2024 | Prospera |
| Vertex Pharmaceuticals Incorporated | $136.39 | 2025 | |
| Mml US, INC. | $135.55 | 2023 | Reactiv8 |
| Allergan, INC. | $99.30 | 2021 | |
| Medtronic, INC. | $84.28 | 2022-2025 | Inceptiv |
| Ipsen Biopharmaceuticals, INC | $75.19 | 2024 | Dysport |
| Esperion Therapeutics, INC. | $28.26 | 2023 | Nexletol |
| Amgen INC. | $23.63 | 2024 | Evenity, Prolia |
| Stryker Corporation | $19.50 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $17.79 | 2023 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Earls listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.